Lixian Xu

1.7k total citations
56 papers, 1.4k citations indexed

About

Lixian Xu is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Lixian Xu has authored 56 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cellular and Molecular Neuroscience, 13 papers in Molecular Biology and 13 papers in Physiology. Recurrent topics in Lixian Xu's work include Pain Mechanisms and Treatments (11 papers), Anesthesia and Neurotoxicity Research (9 papers) and Neuroinflammation and Neurodegeneration Mechanisms (7 papers). Lixian Xu is often cited by papers focused on Pain Mechanisms and Treatments (11 papers), Anesthesia and Neurotoxicity Research (9 papers) and Neuroinflammation and Neurodegeneration Mechanisms (7 papers). Lixian Xu collaborates with scholars based in China, United States and Japan. Lixian Xu's co-authors include Xingchun Gou, Xiao‐Peng Mei, Yajing Mi, Xingchun Gao, Weilin Jin, Na Guo, Wei Wang, Hao Xu, Bin Deng and Wen Wang and has published in prestigious journals such as The EMBO Journal, PLoS ONE and Biomaterials.

In The Last Decade

Lixian Xu

55 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lixian Xu China 23 356 327 266 261 162 56 1.4k
Lorena Arranz Spain 23 539 1.5× 296 0.9× 193 0.7× 146 0.6× 105 0.6× 39 2.1k
Zerong You United States 21 787 2.2× 421 1.3× 190 0.7× 284 1.1× 71 0.4× 45 1.6k
Jin Young Chung South Korea 22 410 1.2× 204 0.6× 170 0.6× 258 1.0× 152 0.9× 102 1.4k
Hitomi Kurinami Japan 25 600 1.7× 668 2.0× 372 1.4× 311 1.2× 84 0.5× 38 1.9k
Hong Shen China 22 652 1.8× 211 0.6× 136 0.5× 253 1.0× 175 1.1× 64 1.6k
Kévin Baranger France 24 516 1.4× 813 2.5× 326 1.2× 284 1.1× 71 0.4× 42 1.8k
Haixia Lü China 24 840 2.4× 287 0.9× 246 0.9× 315 1.2× 321 2.0× 82 1.9k
Tomoya Terashima Japan 21 432 1.2× 334 1.0× 236 0.9× 271 1.0× 78 0.5× 53 1.4k
Peter S. Vosler United States 20 813 2.3× 274 0.8× 248 0.9× 367 1.4× 88 0.5× 41 1.7k
Devin S. Gary United States 26 733 2.1× 264 0.8× 268 1.0× 436 1.7× 228 1.4× 33 1.9k

Countries citing papers authored by Lixian Xu

Since Specialization
Citations

This map shows the geographic impact of Lixian Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixian Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixian Xu more than expected).

Fields of papers citing papers by Lixian Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lixian Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixian Xu. The network helps show where Lixian Xu may publish in the future.

Co-authorship network of co-authors of Lixian Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Lixian Xu. A scholar is included among the top collaborators of Lixian Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lixian Xu. Lixian Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guan, Hua, et al.. (2024). CTRP9: An Anti-Atherosclerotic Factor in ApoE Knockout Mice through Oxidative Stress Inhibition. Frontiers in Bioscience-Landmark. 29(9). 339–339.
2.
Gao, Xingchun, Yajing Mi, Na Guo, et al.. (2020). The mechanism of propofol in cancer development: An updated review. Asia-Pacific Journal of Clinical Oncology. 16(2). e3–e11. 32 indexed citations
3.
Gao, Xingchun, Yajing Mi, Na Guo, et al.. (2018). Glioma in Schizophrenia: Is the Risk Higher or Lower?. Frontiers in Cellular Neuroscience. 12. 289–289. 19 indexed citations
4.
Gao, Xingchun, Yajing Mi, Na Guo, et al.. (2017). Cytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy. Frontiers in Immunology. 8. 774–774. 122 indexed citations
5.
Deng, Bin, et al.. (2016). TAT-PEP Enhanced Neurobehavioral Functional Recovery by Facilitating Axonal Regeneration and Corticospinal Tract Projection After Stroke. Molecular Neurobiology. 55(1). 652–667. 18 indexed citations
6.
Deng, Bin, Xingchun Gou, Hailan Chen, et al.. (2013). Targeted delivery of Neurogenin-2 protein in the treatment for cerebral ischemia-reperfusion injury. Biomaterials. 34(34). 8786–8797. 28 indexed citations
7.
Sun, Xingxing, Tingting Du, Rui Huo, & Lixian Xu. (2013). Hemoglobin A1c as a marker for identifying diabetes and cardiovascular risk factors: the China Health and Nutrition Survey 2009. Acta Diabetologica. 51(3). 353–360. 4 indexed citations
8.
Mei, Xiao‐Peng, Hui Zhang, Wei Wang, et al.. (2011). Inhibition of spinal astrocytic c-Jun N-terminal kinase (JNK) activation correlates with the analgesic effects of ketamine in neuropathic pain. Journal of Neuroinflammation. 8(1). 6–6. 46 indexed citations
9.
Ren, Jun, et al.. (2011). Isoflurane enhances malignancy of head and neck squamous cell carcinoma cell lines: A preliminary study in vitro. Oral Oncology. 47(5). 329–333. 19 indexed citations
11.
Wang, Shuang, Lei Chen, Niansong Qian, et al.. (2011). Spinal Astrocytic Activation Is Involved in a Virally-Induced Rat Model of Neuropathic Pain. PLoS ONE. 6(9). e23059–e23059. 29 indexed citations
12.
Wang, Wei, Xiao‐Peng Mei, Mingming Zhang, et al.. (2011). Neuronal NR2B-containing NMDA receptor mediates spinal astrocytic c-Jun N-terminal kinase activation in a rat model of neuropathic pain. Brain Behavior and Immunity. 25(7). 1355–1366. 50 indexed citations
13.
Wang, Wei, et al.. (2010). Effects of intrathecal isoflurane administration on nociception and Fos expression in the rat spinal cord. European Journal of Anaesthesiology. 28(2). 112–119. 9 indexed citations
14.
Zhang, Hui, Wei Wang, Zhijing Zhao, et al.. (2010). The Action Sites of Propofol in the Normal Human Brain Revealed by Functional Magnetic Resonance Imaging. The Anatomical Record. 293(12). 1985–1990. 13 indexed citations
15.
Gou, Xingchun, Qiang Wang, Qianzi Yang, Lixian Xu, & Lize Xiong. (2010). TAT-NEP1-40 as a novel therapeutic candidate for axonal regeneration and functional recovery after stroke. Journal of drug targeting. 19(2). 86–95. 24 indexed citations
16.
Zhao, Hui, Wei Chai, Wei Gao, et al.. (2009). Hyperoxygenated Solution: Effects on Acute Hypobaric Hypoxia-Induced Oxidative Damage in Rabbits. High Altitude Medicine & Biology. 10(3). 283–291. 12 indexed citations
17.
Zhang, Hui, Wei Wang, Wei Gao, et al.. (2009). Effect of propofol on the levels of neurotransmitters in normal human brain: A magnetic resonance spectroscopy study. Neuroscience Letters. 467(3). 247–251. 26 indexed citations
18.
Gao, Changjun, Xude Sun, Hui Zhang, et al.. (2008). The Effects of Intravenous Hyperoxygenated Solution Infusion on Systemic Oxygenation and Intrapulmonary Shunt During One-Lung Ventilation in Pigs. Journal of Surgical Research. 159(2). 653–659. 10 indexed citations
19.
Li, Mengmeng, Yao‐Qing Yu, Fu Han, et al.. (2008). Extracellular signal-regulated kinases mediate melittin-induced hypersensitivity of spinal neurons to chemical and thermal but not mechanical stimuli. Brain Research Bulletin. 77(5). 227–232. 18 indexed citations
20.
Wang, Ling, Hui Zhang, Changjun Gao, et al.. (2008). Intravenous Administration of Hyperoxygenated Solution Attenuates Pulmonary Edema Formation in Phosgene-Induced Acute Lung Injury in Rabbits. Journal of Surgical Research. 164(1). 131–138. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026